title: Long-term ribavirin therapy for recurrent hepatitis C after liver transplantation.
authors.affiliation: Liver Transplant Program, Toronto Hospital, University of Toronto, Canada.
authors.forename: A A
authors.initials: AA
authors.lastname: Aljumah
authors.forename: M S
authors.initials: MS
authors.lastname: Cattral
authors.forename: P D
authors.initials: PD
authors.lastname: Greig
authors.forename: I R
authors.initials: IR
authors.lastname: Wanless
authors.forename: M
authors.initials: M
authors.lastname: Krajden
authors.forename: A W
authors.initials: AW
authors.lastname: Hemming
authors.forename: L B
authors.initials: LB
authors.lastname: Lilly
authors.forename: G A
authors.initials: GA
authors.lastname: Levy
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000188:drug therapy* / Q000517:prevention & control / Q000601:surgery*; D006801:Humans; D008111:Liver Function Tests; D016031:Liver Transplantation; D011183:Postoperative Complications; D012367:RNA, Viral / Q000097:blood; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000998:Antiviral Agents; D012367:RNA, Viral; D012254:Ribavirin